The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
about
Allergen-specific immunotherapy in pediatric allergic asthmaMechanisms Mediating Pediatric Severe Asthma and Potential Novel Therapies.Omalizumab in children.Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland.Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting.Newer treatments in the management of pediatric asthma.Omalizumab: a review of its use in patients with severe persistent allergic asthma.Omalizumab for severe asthma: efficacy beyond the atopic patient?New strategies with anti-IgE in allergic diseasesPharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma.Asthma referrals: a key component of asthma management that needs to be addressed.Severe asthma and quality of lifeImpact of omalizumab in children from a middle-income country with severe therapy-resistant asthma: A real-life study.The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis.Moving toward consensus on diagnosis and management of severe asthma in children.Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab.Current State and Future of Biologic Therapies in the Treatment of Asthma in Children
P2860
Q26739254-B6A6E4B4-03D1-4170-99F4-27D8000CDF3BQ33871749-31CA645E-FF10-4CA6-9164-E387809F28D7Q34604574-F1A45194-BEE5-46C9-89B2-91782FA2E59DQ34625206-9EB9BB8D-53C7-4D04-9D75-77A7DF1AAA39Q35992096-1D2E9918-E4DA-4F18-90FE-25479ED88ABBQ37428213-A9FB8484-5915-46B0-988B-282A377D07EFQ38113498-495C65F3-5681-437C-AA40-1872691EF054Q38118172-AE10DB79-F133-42D3-B537-2DD27019BC89Q38201304-2A85193A-4E0E-4A29-BC88-70AF56875A8DQ38237389-0B2D1F4B-33F0-40AD-BD05-BB647D805AA5Q38982481-A6143C10-3A08-4639-9C78-963CB1D8332DQ41184141-5598C6E5-7BC5-45CF-A23A-D0292EA91DB2Q41466694-306A912D-1812-45EE-A5DC-30F54D5A0AACQ47611094-2BC50814-5F25-4ED9-9F1F-81C8E8F95146Q47769040-5B64EA7C-B5BB-4731-AC1F-0ACF8895DDC6Q47863226-39EDDCD8-0640-4D5C-91A8-B171713DEFB4Q51118496-127B4E5A-FD2F-45C0-BB32-962391A73810Q55517296-75D8F592-063E-49C1-B9EC-F64994072917Q57128935-26A95E08-F3FD-480D-9707-5DDB0C0CAA9A
P2860
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@ast
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@en
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@nl
type
label
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@ast
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@en
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@nl
prefLabel
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@ast
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@en
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@nl
P2093
P1476
The oral corticosteroid-sparing effect of omalizumab in children with severe asthma.
@en
P2093
David A Spencer
Michael C McKean
Samantha Moss
P304
P356
10.1136/ARCHDISCHILD-2011-301570
P407
P577
2012-06-09T00:00:00Z